Zhong HJ

No ORCID on file · 1 paper in corpus
lab-animal 2025
International journal of nanomedicine ·doi:10.2147/ijn.s497099

PURPOSE: To improve the oral absorption of relugolix (RLGL), which has low oral bioavailability due to its low solubility and being a substrate of P-glycoprotein (P-gp). A solid self-microemulsifying drug delivery system of relugolix (RLGL-…